83H-67037-39241 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-29
Dose 1 — Pfizer-BioNTech
2021-06-18
Dose 2 — Pfizer-BioNTech
2022-02-10
Registered in v-safe
2022-02-10
Dose 3 — Pfizer-BioNTech
2022-02-11
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Chills, Headache

Adult check-in
2022-02-12
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain

Free text: Swollen lymph nodes on right armpit

MedDRA releases: 2024-11 · check-in free text available
2022-02-13
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy, Tachycardia — Feeling: Fair · Site: Pain · Headache

Free text: Lymph node swollen on Right armpit tachycardia

MedDRA releases: 2024-11 · check-in free text available
2022-02-15
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-29	Pfizer-BioNTech	No
2	2021-06-18	Pfizer-BioNTech	No
3	2022-02-10	Pfizer-BioNTech	No

Free text

Release 11 — days 1–6 daily, dose 3

2022-02-12

Systemic reaction (other): Swollen lymph nodes on right armpit

2022-02-13

Systemic reaction (other): Lymph node swollen on Right armpit tachycardia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Lymphadenopathy	·	·	✓
SRO	Tachycardia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release